IBS
Clinical trials for IBS explained in plain language.
Never miss a new study
Get alerted when new IBS trials appear
Sign up with your email to follow new studies for IBS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a tailored mediterranean diet and exercise reverse fatty liver in 3 months?
Disease control CompletedThis study looked at whether two different low-calorie Mediterranean diet plans, combined with moderate aerobic exercise, could improve liver health, gut function, and metabolic risk in 36 adults with obesity and non-alcoholic fatty liver disease (NAFLD). Participants followed on…
Matched conditions: IBS
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
Tomato diet shows promise for fatty liver and gut health
Disease control CompletedThis study looked at whether adding tomatoes to the diet can improve liver health, gut function, and blood sugar in people with non-alcoholic fatty liver disease (NAFLD). 80 adults with NAFLD and a BMI of 30 or less took part. Researchers measured liver fat, inflammation, and gut…
Matched conditions: IBS
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Dietary tweak offers hope for kids with tummy troubles
Symptom relief CompletedThis study tested whether a low FODMAP diet (avoiding certain hard-to-digest carbs) can reduce belly pain and other IBS symptoms in children. 70 kids with IBS, aged 4 to 18, tried both a low FODMAP diet and a standard diet in a crossover design. Researchers measured symptom chang…
Matched conditions: IBS
Phase: NA • Sponsor: University of Bari • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
Gut check: new study probes how IBS drug changes your microbiome
Knowledge-focused CompletedThis study looked at how the drug tenapanor changes the bacteria and chemical activity in the gut of people with irritable bowel syndrome with constipation (IBS-C). Thirty-six adults took tenapanor twice a day for 8 weeks and provided stool samples. The goal was to understand how…
Matched conditions: IBS
Phase: PHASE4 • Sponsor: Kyle Staller, MD, MPH • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC